Abingworth management ltd - see footnote investment history in Alnylam pharmaceuticals inc

Filed on 2005-03-15 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4/a

Accession 0001291892-05-000014.txt Sec File: edgar/data/1178670/0001291892-05-000014-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 16270 shares at $0 remaining shares owned 18745

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f7 2,080 shares that were acquired on may 27, 2004 by abingworth bioventures iii executives l.p., the acquisition of which was reported on a form 4 filed june 1, 2004, were omitted from this form 4 and the subsequent forms 4 filed by the reporting person on january 7, 2005, january 12, 2005 and january 20, 2005.
f8 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management ltd is the manager.


Filed on 2005-03-15 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4/a

Accession 0001291892-05-000014.txt Sec File: edgar/data/1178670/0001291892-05-000014-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 1020902 shares at $0 remaining shares owned 1176269

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f1 130,520 shares that were acquired on may 27, 2004 by abingworth bioventures iii a l.p., the acquisition of which was reported on a form 4 filed june 1, 2004, were omitted from this form 4 and the subsequent forms 4 filed by the reporting person on january 7, 2005, january 12, 2005 and january 20, 2005.
f2 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management ltd is the manager.


Filed on 2005-03-15 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4/a

Accession 0001291892-05-000014.txt Sec File: edgar/data/1178670/0001291892-05-000014-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 623202 shares at $0 remaining shares owned 718037

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f3 79,673 shares that were acquired on may 27, 2004 by abingworth bioventures iii b l.p., the acquisition of which was reported on a form 4 filed june 1, 2004, were omitted from this form 4 and the subsequent forms 4 filed by the reporting person on january 7, 2005, january 12, 2005 and january 20, 2005.
f4 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management ltd is the manager.


Filed on 2005-03-15 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4/a

Accession 0001291892-05-000014.txt Sec File: edgar/data/1178670/0001291892-05-000014-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 373294 shares at $0 remaining shares owned 430112

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f5 47,727 shares that were acquired on may 27, 2004 by abingworth bioventures iii c l.p., the acquisition of which was reported on a form 4 filed june 1, 2004, were omitted from this form 4 and the subsequent forms 4 filed by the reporting person on january 7, 2005, january 12, 2005 and january 20, 2005.
f6 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth management ltd is the manager.


Filed on 2005-03-10 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4/a

Accession 0001209191-05-014766.txt Sec File: edgar/data/1178670/0001209191-05-014766-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 130520 shares at $6.00 remaining shares owned 155367

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: P Open market or private purchase of securities

f1 this amendment is being filed to correct the date of this transaction, which was incorrect in the reporting person's original form 4.
f2 these shares were purchased directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.


Filed on 2005-01-20 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000006.txt Sec File: edgar/data/1178670/0001291892-05-000006-index.htm

2005-01-18 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 21668 shares at $8.482 remaining shares owned 873480

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.


Filed on 2005-01-20 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000006.txt Sec File: edgar/data/1178670/0001291892-05-000006-index.htm

2005-01-18 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 13227 shares at $8.482 remaining shares owned 533199

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.


Filed on 2005-01-20 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000006.txt Sec File: edgar/data/1178670/0001291892-05-000006-index.htm

2005-01-18 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 7923 shares at $8.482 remaining shares owned 319399

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth management limited is the manager.


Filed on 2005-01-20 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000006.txt Sec File: edgar/data/1178670/0001291892-05-000006-index.htm

2005-01-18 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 345 shares at $8.482 remaining shares owned 13918

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-12 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 918 shares at $9.30 remaining shares owned 327322

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-12 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 1532 shares at $9.30 remaining shares owned 546426

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-11 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 160 shares at $9.8525 remaining shares owned 14303

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-12 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 2510 shares at $9.30 remaining shares owned 895148

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-11 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 3671 shares at $9.8525 remaining shares owned 328240

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-11 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 6129 shares at $9.8525 remaining shares owned 547958

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-11 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 10040 shares at $9.8525 remaining shares owned 897658

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-10 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 600 shares at $9.866 remaining shares owned 14463

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-10 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 13767 shares at $9.866 remaining shares owned 331911

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-10 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 22983 shares at $9.866 remaining shares owned 554087

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-10 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 37650 shares at $9.866 remaining shares owned 907698

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.


Filed on 2005-01-12 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001291892-05-000003.txt Sec File: edgar/data/1178670/0001291892-05-000003-index.htm

2005-01-12 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 40 shares at $9.30 remaining shares owned 14263

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-05 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 30644 shares at $8.0668 remaining shares owned 607714

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f2 these shares are owned directly by abingworth bioventrues iii b l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-06 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 18356 shares at $8.6975 remaining shares owned 345678

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f3 these shares are owned directly by abingworth bioventrues iii c l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-06 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 30644 shares at $8.6975 remaining shares owned 577070

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f2 these shares are owned directly by abingworth bioventrues iii b l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-06 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 50200 shares at $8.6975 remaining shares owned 945348

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f1 these shares are owned directly by abingworth bioventrues iii a l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-05 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 800 shares at $8.0668 remaining shares owned 15863

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f4 these shares are owned directly by abingworth bioventrues iii executives l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-05 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 18356 shares at $8.0668 remaining shares owned 364034

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f3 these shares are owned directly by abingworth bioventrues iii c l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-06 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 800 shares at $8.6975 remaining shares owned 15063

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f4 these shares are owned directly by abingworth bioventrues iii executives l.p., of which abingworth management limited is the manager.


Filed on 2005-01-07 by Alnylam Pharmaceuticals, Inc. SEC CIK 1178670 Form 4

Accession 0001072613-05-000041.txt Sec File: edgar/data/1178670/0001072613-05-000041-index.htm

2005-01-05 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 50200 shares at $8.0668 remaining shares owned 995548

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: S Open market or private sale of securities

f1 these shares are owned directly by abingworth bioventrues iii a l.p., of which abingworth management limited is the manager.


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 832 shares at $0 remaining shares owned 0

Series C Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 437 underlying security title Common Stock

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 19085 shares at $0 remaining shares owned 0

Series C Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 10044 underlying security title Common Stock

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth manager limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 31861 shares at $0 remaining shares owned 0

Series C Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 16768 underlying security title Common Stock

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 52194 shares at $0 remaining shares owned 0

Series C Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 27470 underlying security title Common Stock

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 22080 shares at $0 remaining shares owned 0

Series B Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 11621 underlying security title Common Stock

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 506626 shares at $0 remaining shares owned 0

Series B Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 266645 underlying security title Common Stock

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth manager limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 845774 shares at $0 remaining shares owned 0

Series B Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 445144 underlying security title Common Stock

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 1385520 shares at $0 remaining shares owned 0

Series B Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 729221 underlying security title Common Stock

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 8000 shares at $0 remaining shares owned 0

Series A Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 4210 underlying security title Common Stock

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 183560 shares at $0 remaining shares owned 0

Series A Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 96610 underlying security title Common Stock

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth manager limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 306440 shares at $0 remaining shares owned 0

Series A Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 161284 underlying security title Common Stock

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc sold 502000 shares at $0 remaining shares owned 0

Series A Convertible Preferred Stock Alnylam Pharmaceuticals Inc Alny underlying security shares 264210 underlying security title Common Stock

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.
f5 each share of series a, b and c preferred stock automatically converted into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
f6 n/a


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 162688 shares at $0 remaining shares owned 16663

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f4 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 373299 shares at $0 remaining shares owned 382390

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f3 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth manager limited is the manager.


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 623196 shares at $0 remaining shares owned 638358

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f2 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.


Filed on 2004-06-07 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-029955.txt Sec File: edgar/data/1178670/0001209191-04-029955-index.htm

2004-06-03 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 1020901 shares at $0 remaining shares owned 1045748

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: C Conversion of derivative security (usually options)

f1 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.


Filed on 2004-06-01 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-028932.txt Sec File: edgar/data/1178670/0001209191-04-028932-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 2080 shares at $6.00 remaining shares owned 2475

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: P Open market or private purchase of securities

f4 these shares were purchased directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.


Filed on 2004-06-01 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-028932.txt Sec File: edgar/data/1178670/0001209191-04-028932-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 47727 shares at $6.00 remaining shares owned 56818

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: P Open market or private purchase of securities

f3 these shares were purchased directly by abingworth bioventures iii c l.p., of which abingworth management limited is the manager.


Filed on 2004-06-01 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-028932.txt Sec File: edgar/data/1178670/0001209191-04-028932-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 79673 shares at $6.00 remaining shares owned 94835

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: P Open market or private purchase of securities

f2 these shares were purchased directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.


Filed on 2004-06-01 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 4

Accession 0001209191-04-028932.txt Sec File: edgar/data/1178670/0001209191-04-028932-index.htm

2005-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc bought 130520 shares at $6.00 remaining shares owned 155367

Common Stock Alnylam Pharmaceuticals Inc Alny Transaction code: P Open market or private purchase of securities

f1 these shares were purchased directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.


Filed on 2004-05-27 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 3

Accession 0001209191-04-028440.txt Sec File: edgar/data/1178670/0001209191-04-028440-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc remaining shares owned 395

Common Stock Alnylam Pharmaceuticals Inc Alny

f1 reflects a 1-for-1.9 reverse stock split, which became effective on may 7, 2004.
f5 these shares are owned directly by abingworth bioventures iii executives l.p., of which abingworth management limited is the manager.


Filed on 2004-05-27 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 3

Accession 0001209191-04-028440.txt Sec File: edgar/data/1178670/0001209191-04-028440-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc remaining shares owned 9091

Common Stock Alnylam Pharmaceuticals Inc Alny

f1 reflects a 1-for-1.9 reverse stock split, which became effective on may 7, 2004.
f4 these shares are owned directly by abingworth bioventures iii c l.p., of which abingworth management limited is the manager.


Filed on 2004-05-27 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 3

Accession 0001209191-04-028440.txt Sec File: edgar/data/1178670/0001209191-04-028440-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc remaining shares owned 15162

Common Stock Alnylam Pharmaceuticals Inc Alny

f1 reflects a 1-for-1.9 reverse stock split, which became effective on may 7, 2004.
f3 these shares are owned directly by abingworth bioventures iii b l.p., of which abingworth management limited is the manager.


Filed on 2004-05-27 by Alnylam Pharmaceuticals Inc SEC CIK 1178670 Form 3

Accession 0001209191-04-028440.txt Sec File: edgar/data/1178670/0001209191-04-028440-index.htm

2004-05-27 Abingworth Management Ltd (CIK 1291892) through See Footnote

Invested in Alnylam Pharmaceuticals Inc remaining shares owned 24847

Common Stock Alnylam Pharmaceuticals Inc Alny

f1 reflects a 1-for-1.9 reverse stock split, which became effective on may 7, 2004.
f2 these shares are owned directly by abingworth bioventures iii a l.p., of which abingworth management limited is the manager.